Featured Research

from universities, journals, and other organizations

Pay-for-performance programs show positive impact on low-performing physicians

Date:
February 19, 2010
Source:
Wiley-Blackwell
Summary:
Pay-for-performance (P4P) programs are payment models that reward workers for meeting certain performance measures for quality and efficiency. In the health care setting, P4P programs use a variety of methods to reward physicians financially for achieving targets, including fee differentials and bonuses.

Pay-for-performance (P4P) programs are payment models that reward workers for meeting certain performance measures for quality and efficiency. In the healthcare setting, P4P programs use a variety of methods to reward physicians financially for achieving targets, including fee differentials and bonuses.

A new study in the Journal for Healthcare Quality reveals that P4P programs appear to be effective in incentivizing low performing physicians. The article is part of the January/February 2010 special issue on pay-for-performance in the health care system.

Judy Ying Chen, Ning Kang, Deborah Taira Juraez, Krista A. Hodges, and Richard S. Chung investigated the impact of P4P in a Preferred Provider Organization (PPO) on low performing physicians over a four year period.

Results found that a P4P program in a PPO setting can improve quality of care. This was true especially for selected quality measures, such as mammography, cervical cancer screening, and childhood immunization measures. The low performing physicians using P4Pimproved significantly more than the comparison group (which did not implement a P4P program) for many measures. In addition, the study found that the positive benefit of the P4P program may not be realized until the 3rd or 4th year, highlighting the importance of sustaining P4P over longer periods of time..

"Our findings reveal that a P4P program appears to be effective in incentivizing low performing physicians to sustain improvement," the authors note.


Story Source:

The above story is based on materials provided by Wiley-Blackwell. Note: Materials may be edited for content and length.


Cite This Page:

Wiley-Blackwell. "Pay-for-performance programs show positive impact on low-performing physicians." ScienceDaily. ScienceDaily, 19 February 2010. <www.sciencedaily.com/releases/2010/02/100219135417.htm>.
Wiley-Blackwell. (2010, February 19). Pay-for-performance programs show positive impact on low-performing physicians. ScienceDaily. Retrieved July 30, 2014 from www.sciencedaily.com/releases/2010/02/100219135417.htm
Wiley-Blackwell. "Pay-for-performance programs show positive impact on low-performing physicians." ScienceDaily. www.sciencedaily.com/releases/2010/02/100219135417.htm (accessed July 30, 2014).

Share This




More Health & Medicine News

Wednesday, July 30, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Health Insurers' Profits Slide

Health Insurers' Profits Slide

Reuters - Business Video Online (July 30, 2014) Obamacare-related costs were said to be behind the profit plunge at Wellpoint and Humana, but Wellpoint sees the new exchanges boosting its earnings for the full year. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Concern Grows Over Worsening Ebola Crisis

Concern Grows Over Worsening Ebola Crisis

AFP (July 30, 2014) Pan-African airline ASKY has suspended all flights to and from the capitals of Liberia and Sierra Leone amid the worsening Ebola health crisis, which has so far caused 672 deaths in Guinea, Liberia and Sierra Leone. Duration: 00:43 Video provided by AFP
Powered by NewsLook.com
At Least 20 Chikungunya Cases in New Jersey

At Least 20 Chikungunya Cases in New Jersey

AP (July 30, 2014) At least 20 New Jersey residents have tested positive for chikungunya, a mosquito-borne virus that has spread through the Caribbean. (July 30) Video provided by AP
Powered by NewsLook.com
Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins